Insights on the Dengue Vaccines Global Market to 2031 – Featuring Sanofi Pasteur, GlaxoSmithKline and VabioTech Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Dengue Vaccines Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

The report on the global dengue vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global dengue vaccines market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dengue vaccines market from 2021 to 2031.

The report has been prepared after extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dengue vaccines market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the dengue vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dengue vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dengue vaccines market.

The report delves into the competitive landscape of the global dengue vaccines market. Key players operating in the global dengue vaccines market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dengue vaccines market profiled in this report.

Companies Mentioned

• Sanofi Pasteur Limited
• Takeda Pharmaceutical Company Limited
• Merck Co. & Inc.
• GlaxoSmithKline plc
• GeneOne Life Science
• Medigen Vaccine Biologics
• Panacea Biotec Limited
• Sun Pharmaceutical Industries Ltd.
• Serum Institute of India Pvt. Ltd.
• Biological E
• VabioTech

Key Questions Answered in the Report

• What is the sales/revenue generated by dengue vaccines across all regions during the forecast period?
• What are the opportunities in the global dengue vaccines market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which category is expected to generate the highest revenue globally in 2031? Which product is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Dengue Vaccines Market

4. Market Overview

4.1. Introduction

4.1.1. Category Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Dengue Vaccines Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis

5.2. Disease Prevalence

5.3. Patient Volume

5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Dengue Vaccines Market Analysis and Forecast, by Category

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Category, 2017-2031

6.3.1. Live Attenuated Vaccines

6.3.2. Chimeric Live Attenuated Vaccines

6.3.3. Others

6.4. Market Attractiveness Analysis, by Category

7. Global Dengue Vaccines Market Analysis and Forecasts, by Product

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Product, 2017-2031

7.3.1. CYD-TDV (Dengvaxia)

7.3.2. Others

7.4. Market Attractiveness Analysis, by Product

8. Global Dengue Vaccines Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Route of Administration, 2017-2031

8.3.1. Subcutaneous

8.3.2. Others

8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Dengue Vaccines Market Analysis and Forecast, by End-user

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by End-user, 2017-2031

9.3.1. Hospitals

9.3.2. Government Institutes

9.3.3. Specialty Clinics

9.3.4. Others

9.4. Market Attractiveness Analysis, by End-user

10. Global Dengue Vaccines Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast By Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness Analysis, by Country/Region

11. North America Global Dengue Vaccines Market Analysis and Forecast

12. Europe Global Dengue Vaccines Market Analysis and Forecast

13. Asia Pacific Global Dengue Vaccines Market Analysis and Forecast

14. Latin America Global Dengue Vaccines Market Analysis and Forecast

15. Middle East & Africa Global Dengue Vaccines Market Analysis and Forecast

16. Competition Landscape

16.1. Market Share Analysis, by Company, 2020

16.2. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/qmhdmb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900